Chlamydia trachomatis screening in the adolescent population

Current Opinion in Pediatrics

Volumn 9, Issue 4, 1997, Pages 317-324

  Holder, David W ^a   Woods, Elizabeth R ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

ADOLESCENT; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COST EFFECTIVENESS ANALYSIS; GENE AMPLIFICATION; GYNECOLOGICAL EXAMINATION; HUMAN; NONHUMAN; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; REVIEW; SCREENING; URINALYSIS;

EID: 0030882407     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199708000-00004     Document Type: Review

References (62)

1. Quinn TC: DNA amplification assays: a new standard for diagnosis of Chlamydia trachomatis infections. Ann Acad Med Singapore 1995, 24:627-633.
2. Centers for Disease Control and Prevention: Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR Morb Mortal Wkly Rep 1993, 42:1-39.
3. Committee on Prevention and Control of Sexually Transmitted Diseases, Institute of Medicine, Division of Health Promotion and Disease Prevention: Summary, The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Edited by Eng TR, Butler WT. Washington, DC: National Academy Press; 1997. Excellent summary of the current public health issues.
4. Centers for Disease Control and Prevention: Chlamydia trachomatis genital infections: United States, 1995. MMWR Morb Mortal Wkly Rep 1997, 46:193-198. Included in this brief update of the epidemiology, screening, and partner treatment issues for C. trachomatis is an expansion of the authors' prior recommendations to screen adolescent girls and women under 20 years to under 30 years of age. Use of DAA tests on urine may expand screening, and single-dose azythromycin (1 g) provides effective treatment.
5. Mousure DJ, Berman S, Fine D, Delisle S, Cates W, Boring JR: Genital chlamydia infections in sexually active female adolescents: do we really need to screen everyone? J Adolesc Med 1997, 20:6-13. This study evaluates the individuals' risk behaviors and likelihood of chlamydia infection in 15-to 19-year-olds. No single risk factor or pattern could identify more than 42% of the patients with C. trachomatis; therefore, universal screening was still recommended.
6. Centers for Disease Control and Prevention: Sexually Transmitted Disease Surveillance, 1994. Atlanta: Centers for Disease Control and Prevention; 1995.
7. Magder LS, Harrison HR, Ehret JM, Anderson TS, Judson FN: Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol 1988, 28:298-308.
8. Shafer M-A, Schachter J, Moscicki AB, Weiss A, Shalwitz J, Vaghan E, Millstein S: Urinary leukocyte esterase screening test for asymptomatic chlamydial and gonococcal infections in males. JAMA 1989, 262:2562-2566.
9. Biro FM, Rosenthal SL, Kiniyalocts M: Gonococcal and chlamydial genitourinary infections in symptomatic and asymptomatic adolescent women. Clin Pediatr 1995, 34:419-423.
10. Schachter J, Stoner E, Moncada J: Screening for chlamydial infections in women attending family planning clinics. West J Med 1983, 138:375-379.
11. Centers for Disease Control and Prevention: Pelvic inflammatory disease: guidelines for prevention and management. MMWR Morb Mortal Wkly Rep 1991, 40(RR-5):1-25.
12. Schachter J, Grossman M, Sweet RL, Holt J, Jordan C, Bishop E: Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA 1986, 255:3374-3377.
13. Robertson DHH, McMillan A, Young H: Non-gonococcal urethritis, chlamydial infections and other related conditions. In Clinical Practice in Sexually Transmissible Diseases, edn 2. Edinburgh: Churchill Livingstone; 1989.
14. Greendale GA, Haas ST, Holbrook K, Walsh B, Schachter J, Phillips RS: The relationship of Chlamydia trachomatis infection and male infertility. Am J Public Health 1993, 83:996-1001.
15. Wasserheit JN: Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992, 19:61-77.
16. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzilz N, Goeman J, Behets F, Batter V, Alary M, Heyward WL, Ryder RW, Piot P: Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993, 7:95-102.
17. Stamm WE and Cole B: Asymptomatic Chlamydia trachomatis urethritis in men. Sex Transm Dis 1986, 13:163-165.
18. Black CM: Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997, 10:160-184. An outstanding comprehensive review of the laboratory diagnosis of C. trachomatis and its clinical implications.
19. Phillips RS, Aronson MD, Taylor WC, Safran C: Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits: an analysis of the costs of alternative strategies. Ann Intern Med 1987, 107:188-194.
20. Chacko MR, Cromer BA, Phillips SA, Glasser D: Failure of lottery incentives to increase compliance with return visit for test-of-cure culture for Neisseria gonorrhoeae. Sex Transm Dis 1987, 14:75-78.
21. Woods ER, Galvez LM, Talis AL, Emans SJ: First catch urine sediment for Chlamydia trachomatis and Neisseria gonorrhoeae culture in adolescent males with pyuria. J Adolesc Health 1991, 12:329-334.
22. Schachter J, Stamm WE: Chlamydia. In Manual of Clinical Microbiology, edn 6. Edited by Murray PR, Pfaller MA, Tenover FC, and Yolken RH: Washington DC: American Society for Microbiology; 1995:669-677.
23. Biro FM, Raising SF, Doughman JA, Koller LM, Rosenthal SL: A comparison of diagnostic methods in adolescent girls with and without symptoms or Chlamydia urogenital infection. Pediatrics 1994, 93:476-480.
24. Clarke LM, Sierra MF, Diadone BJ, Lopez N, Covino JM, McCormack WM: Comparison of the Syva Mircrotrak enzyme immunoassay and Gen-Probe PACE 2 with cell culture for diagnosis of cervical Chlamydia trachomatis infection in a high-prevalence female population. J Clin Microbiol 1993, 31:968-971.
25. Sadof MD, Woods ER, Emans SJ: Dipstick leukocyte esterase activity in first-catch urine specimens: a useful screening test for detecting sexually transmitted disease in the adolescent male. JAMA 1987, 258:1932-1934.
26. O'Brien SF, Bell TA, Farrow JA: Use of leukocyte dipstick to detect Chlamydia trachomatis and Neisseria gonorrhoeae urethritis in asymptomatic adolescent male detainees. Am J Public Health 1988, 78:1582-1584.
27. Sellors JM, Mahony JB, Pickard L, Jeng D, Groves D, Luinstra KE, Chernesky MA: Screening urine with a leukocyte esterase strip and subsequent chlamydial testing of asymptomatic men attending primary care practitioners. Sex Transm Dis 1993, 20:152-157.
28. Crotchfelt KA, Pare B, Gaydos C, Quinn TC: Detection of Chlamydia trachomatis by the Gen-Probe Transcription Mediated Amplification (TMA) assay in male urine specimens and female endocervical and urine specimens [abstract]. In Proceedings, Third Meeting of the European Society for Chlamydia Research. Edited by Stary A. 1996. A clear description of this new RNA technology with results compared with culture and discrepancies resolved by DFA for endocervical and urine specimens from 479 men and women.
29. Pasternack R, Vuorinen P, Meittinen A: Evaluation of Gen-Probe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women. J Clin Microbiol 1997, 35:676-678. A recent paper evaluating transcription-mediated amplification in women compared with culture and PCR.
30. Adger H, Schafer M-A, Sweet R, Schactiter J: Screening for Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent males: value of first catch urine examination. Lancet 1984, ii:944-945.
31. Blythe MJ, Fortenberry D, Orr D, Jones R: Utilization of leukocyte esterase test in screening adolescent males in preparticipation sports physicals for sexually transmitted infections and bacteria [abstract]. Society for Adolescent Medicine Annual Meeting; 1997.
32. Johnson J, Neas B, Parker DE, Fortenberry JD, Cowan LD: Screening for uretheral infection in adolescent and young adult males. J Adolesc Health 1993, 14:356-361.
33. Orr DP: Urine-based diagnosis of sexually transmitted infections using amplified DNA techniques: a shift in paradigms? J Adolesc Health 1997, 20:3-5. An excellent discussion of the value of PCR or LCR screening in the adolescent population. Comparative costs of different screening tests is also provided.
34. Chernesky MA, Jang D, Sellors S, Castricino S, Pickard L, Luinstra K, Mahony J: Confirmatory testing demonstrates that false positive rates in the Chlamydiazyme assay are influenced by gender and genital specimen type. Sex Transm Dis 1993, 20:301-306.
35. Chernesky M, Castricciano S, Sellors J: Detection of Chlamydia trachomatis antigens in urine as an alternative to swabs and cultures. J Infect Dis 1990, 161:124-126.
36. Paul ID, Caul EO: Evaluation of three Chlamydia trachomatis immunoassays with an unbiased, noninvasive clinical sample. J Clin Microbiol 1990, 28:220-222.
37. Mares I, Jarnmark O, Kandell B, Ekegren M-B, Svensson L, Vilhemsson B, Forsman L: Screening for asymptomatic Chlamydia trachomatis infection in adolescent men by examination of voided urine. Genitourin Med 1992, 68:344-345.
38. Leonardi G, Seitz M, Edstrom R, Cruz J, Costello P, Szabo K: Evaluation of three immunoassays for detection of Chlamydia trachomatis in urine specimens from asymptomatic males. J Clin Microbiol 1992, 30:2793-2796.
39. Woods ER, Rome ES, Wolfson DH, Spencer SE, Emans SJ: First-catch urine sediment for C. trachomatis and gram stain for N. gonorrhoeae in adolescent males. Clin Perform Qual Health Care 1997, in press.
40. Shafer M-A, Schachter J, Moncada J, Keogh J, Pantell R, Gourlay L, Eyre S, Boyer CB: Evaluation of urine-based screening strategies to detect Chlamydia trachomatis among sexually active asymptomatic young males. JAMA 1993, 270:2065-2070.
41. Genç M, Ruusuvaara L, Márdh P-A: An economic evaluation of screening for Chlamydia trachomatis in adolescent males. JAMA 1993, 270:2057-2064.
42. Schachter J, Stamm WE, Quinn TC, Andrews WW, Burczak JD, Lee HH: Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol 1994, 32:2540-2543.
43. Lee HH, Chernesky MA, Schachter J, Burczak JD, Andrews WW, Muldoon S, Leckie G, Stamm WE: Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995, 345:213-216.
44. Dille BJ, Butzen CC, Birkenmeyer LG: Amplification of Chlamydia trachomatis DNA by ligase chain reaction. J Clin Microbiol 1993, 31:729-731.
45. Chernesky MA, Lee H, Schochter J, Burczak JD, Stamm WE, McCormack WM, Quinn TC: Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine ligase chain reaction assay. J Infect Dis 1994, 170:1308-1311.
46. Chernesky MA, Jang D, Lee H, Burczak JD, Hu H, Sellors J, Tomazic-Allen SJ, Mahony JB: Diagnosis of Chlamydia trachomatis infections in men and women by testing first-catch urine by ligase chain reaction. J Clin Microbiol 1994, 32:2682-2685.
47. Anestad G, Berdal BP, Schell O, Mundal R, Odinsen O, Skaug K, Khalih OS, Plier P, Lee H: Screening urine samples by leukocyte esterase test and ligase chain reaction for chlamydial infections among asymptomatic men. J Clin Microbiol 1995, 33:2483-2484.
48. Gilroy CB, Thomas BJ, Taylor-Robinson D: Small numbers of Chlamydia trachomatis elementary bodies on slides detected by polymerase chain reaction. J Clin Pathol 1992, 45:531-532.
49. Rasmussen SJ, Smith-Vaughan H, Nelson M, Chan SW, Timms P, Capin AG: Detection of Chlamydia trachomatis in urine using enzyme immunoassay and DNA amplification. Mol Cell Probes 1993, 7:425-430.
50. Bauwens JE, Clarke AM, Stamm WE: Diagnosis of Chlamydia trachomatis endocervical infection by a commercial polymerase chain reaction assay. J Clin Microbiol 1993, 31:3023-3027.
51. Workowski KA, Lampe MF, Wong KG, Watts MD, Stamm WE: Long term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy: evidence against persistent infections. JAMA 1993, 270:2071-2075.
52. Mahony JB, Luinstra KE, Sellors JW, Jang D, Chernesky MA: Confirmatory polymerase chain reaction testing for Chlamydia trachomatis in first-void urine from asymptomatic and symptomatic men. J Clin Microbiol 1992, 270:2241-2245.
53. Mahony JB, Linstra KE, Jang D, Sellors J, Chernesky MA: Chlamydia trachomatis confirmatory testing of PCR-positlve genitourinary specimens using a second set of plasmid primers. Molecular Cellular Probes 1992, 6:381-388.
54. Hanff PA, Cheng A, Shapiro D, Coffey D, Spencer S, Melchiono M, Holder D, Woods E, and the Boston Collaborative Chlamydia trachomatis Study Group: Detection of Chlamydia trachomatis in male and female urine by PCR. Twelfth Annual Clinical Virology Symposium and Annual Meeting, Pan American Society for Clinical Virology, 1996.
55. Genç M, Merdh P-A: An cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996, 124:1-7.
56. Genç M, Mårdh PA: A cost-effectiveness screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996, 124:1-7. An excellent cost-effectiveness analysis using periodic DAA urine screening of asymptomatic women.
57. Davies HD, Wang EEL, with the Canadian Task Force on the periodic health examination. Can Med Assoc J 1996, 154:1631-1644. An analysis of the age and risk groups recommended for routine screening.
58. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE: Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996, 334:1362-1366. This evaluation of a large health maintenance organization cohort shows that screening by young age and other risk factors was important in reducing pelvic inflammatory disease.
59. Centers for Disease Control and Prevention. 1993 Sexually Transmitted Diseases Treatment Guidelines. MMWR Morb Mortal Wkly Rep 1993, 42:RR-14.
60. Laras L, Craighill M, Woods ER, Emans SJ: Epidemiologic observations of adolescents with Neisseria gonorrhoeae genital infections treated at Children's Hospital. Adolesc Pediatr Gynecol 1994, 7:9-12.
61. Hillis SD, Nakashima A, Marchbanks PA, Addiss DG, Davis JP: Risk factors for recurrent Chlamydia trachomatis infections in women. Am J Obstet Gynecol 1994, 170:801-806.
62. Oh MR, Boker JR, Genuardi FJ, Cloud GA, Reynolds J, Hodgens JB: Sexual contact tracing outcome in adolescent chlamydia and gonococcal cervicitis cases. J Adolesc Health 1996, 18:4-9. Clearly presents the issues around the treatment of adolescent partners.